Corindus prices a stock offering worth nearly $42 million at $3.80 per share as it uplists from the OTC to the New York Stock Exchange.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1cneKTC
Cap comentari:
Publica un comentari a l'entrada